Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6967)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bockmann JH, Dandri M, Lüth S, Pannicke N, Lohse AW. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure. World J Gastroenterol 2015; 21(7): 2214-2219 [PMID: 25717260 DOI: 10.3748/wjg.v21.i7.2214] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2214.htm |
| Number | Citing Articles |
| 1 |
Cheng-Xi Sun, Li-Yan Han, Kai Wang, Shuai Gao. Serum Exosomal Long Noncoding RNA Growth Arrest-Specific 5 Predicts 3-Month Mortality in Acute-on-Chronic Hepatitis B Liver Failure. Journal of Inflammation Research 2023; : 4603 doi: 10.2147/JIR.S423321
|
| 2 |
Tomoko Tadokoro, Asahiro Morishita, Teppei Sakamoto, Shintaro Fujihara, Koji Fujita, Shima Mimura, Kyoko Oura, Takako Nomura, Joji Tani, Hirohito Yoneyama, Hisakazu Iwama, Takashi Himoto, Toshiro Niki, Mitsuomi Hirashima, Tsutomu Masaki. Galectin-9 ameliorates fulminant liver injury. Molecular Medicine Reports 2017; 16(1): 36 doi: 10.3892/mmr.2017.6606
|
| 3 |
Ping Fang Hu, Wei Fen Xie. Corticosteroid therapy in drug‐induced liver injury: Pros and cons. Journal of Digestive Diseases 2019; 20(3): 122 doi: 10.1111/1751-2980.12697
|
| 4 |
Chao Ye, Wenyuan Li, Lei Li, Kaiguang Zhang. Glucocorticoid Treatment Strategies in Liver Failure. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.846091
|
| 5 |
Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure. World Journal of Gastroenterology 2015; 21(36): 10485-10486 doi: 10.3748/wjg.v21.i36.10485
|
| 6 |
He Wang, Yu Qian, Jing-Wen Wang, Yu Fang, Yu-Chen Fan, Hui-Hui Liu, Kai Wang. Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure. International Health 2023; 15(1): 19 doi: 10.1093/inthealth/ihac003
|
| 7 |
Teng-Yu Lee, Chi-Yi Chen, Hsueh-Chou Lia, Yu-Chung Hsu, Sheng-Shun Yang. The Ultra-Short Virological Dynamics in Response to Entecavir or Lamivudine during Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Antiviral Therapy 2018; 23(1): 77 doi: 10.3851/IMP3183
|
| 8 |
Xi Ran, Qiong Fang Zhang, Ling Luo, Da Zhi Zhang, Wei Li. The Efficacy and Safety of Glucocorticoids Plus Conventional Therapy for Hepatitis B-Related Liver Failure in China: A Meta-Analysis. Hepatitis Monthly 2019; 19(6) doi: 10.5812/hepatmon.65787
|
| 9 |
Julia Ettich, Julia Werner, Hendrik T. Weitz, Eva Mueller, Roland Schwarzer, Philipp A. Lang, Jürgen Scheller, Jens M. Moll, Tom Gallagher.
A Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6
trans
-Signaling and Cellular Infection with SARS-CoV-2
. Journal of Virology 2022; 96(4) doi: 10.1128/jvi.01622-21
|
| 10 |
|
| 11 |
Zehao Xiao, Wen Xiao, Guilin Li, Md. Areeful Haque. Research Progress on the Pharmacological Action of Schisantherin A. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6420865
|
| 12 |
Chen-Rui Liu, Ya-Ping Li, Dan-Dan Feng, Shuang-Suo Dang. Hot topics and difficult problems in diagnosis and treatment of end-stage liver disease with fungal infection. World Chinese Journal of Digestology 2020; 28(6): 203 doi: 10.11569/wcjd.v28.i6.203
|